Servier is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science and tackle underserved therapeutic areas with a focus on making patients central to strategic decisions. The company develops innovative medications across therapeutic areas including oncology, with specific focus on solid tumors such as Low Grade Glioma and Cholangiocarcinoma. Servier operates across all phases of clinical development and has established commercial operations in the U.S. market.
Industry
Biopharmaceutical
Company Size
51-200 employees
Founded
2018
Remote Policy
Hybrid
Beta · Sourced from candidate reports
Be the first to share your experience with SERVIER MONDE.
Your reply helps other candidates know what to expect.
